AGTR1 and ovarian cystadenoma: Our prior studies showed that AT1R expression was almost absent in benign ovarian cystadenoma, but was dramatically upregulated with progression from borderline malignancy to invasive ovarian carcinoma (Suganuma et al, 2005).